The solute carrier gene family 26 (SLC26) encodes membrane proteins with diverse physiological roles but with the common feature of halide involvement. Here, we present bioinformatic and biochemical evidence that SLC26 proteins have intrinsically disordered regions (IDRs) in their C-terminal domains and that these regions contain calmodulin (CaM) binding sites. The veracity of these predictions and the functional consequences of CaM binding were examined in prestin, SLC26A5, as a model for the SLC26 family and as one of the most investigated and best understood members. We found that CaM binds directly to the IDR in the C-terminal domain of prestin in a calcium-obligate manner. Using both isolated murine outer hair cells (OHCs) and a heterologous expression system, we also found that this calcium-obligate CaM binding shifts the operating point of the protein to more hyperpolarized potentials with consequent alteration of the function of the prestin. Because calcium is the main intracellular second messenger used by the efferent medial olivocochlear (MOC) pathway of the auditory system and CaM is abundant in OHCs, the CaM-prestin interaction may be involved in the MOC-mediated modulation of cochlear amplification. However, this regulatory mechanism is not likely to be restricted to cochlear OHCs, in light of both clear bioinformatic evidence and the fact that calcium and CaM are ubiquitous intracellular second messengers used by virtually all cell types. Hence, the calcium/CaM-dependent regulatory mechanism described herein is likely applicable to most, if not all, SLC26 paralogs.
Introduction
Most solute carrier gene family 26 (SLC26) paralogs function as anion exchangers, whereas others are anion channels or even voltage-operated molecular motors (Alper and Sharma, 2013) , with the common theme of halide involvement. Not surprisingly, mutations in SLC26 proteins are responsible for a variety of severe disorders, such as chondrodysplasias, Pendred's syndrome, congenital chloride diarrhea, deafness, and numerous others (for review, see Kere, 2006) . Defining the regulatory mechanisms of SLC26 proteins is thus important for understanding both normal and pathological physiological processes. The relatively high sequence similarity with conserved tetrameric subunit stoichiometry between the SLC26 proteins (Hallworth et al., 2013) implies general functional and regulatory mechanisms shared among the family despite their distinct transport substrates. Consistent with this possibility, modulatory interactions with the cystic fibrosis transmembrane conductance regulator (CFTR) protein have been reported for several SLC26 paralogs (Ko et al., 2004; Chang et al., 2009; Homma et al., 2010; Rode et al., 2012) . In addition, the fact that the functions of some SLC26 paralogs have been shown to be affected by manipulating intracellular calcium concentrations (Frolenkov et al., 2000; Loriol et al., 2008; Lamprecht et al., 2009; Keller et al., 2013) further points to the presence of a generalized regulatory mechanism shared among the family.
Prestin (SLC26A5; Zheng et al., 2000) is one of the best characterized members in the SLC26 family in terms of both structure (Pasqualetto et al., 2010) and function (Ashmore, 2008) . Although non-mammalian prestin homologs are transporters, mammalian prestin homologs are expressed exclusively in outer hair cells (OHCs) of the cochlea, in which they act both as voltage-operated motors (Zheng et al., 2000) and weak transporters (Mistrík et al., 2012) . The resulting voltage-dependent somatic motility, often referred to as OHC electromotility (Brownell et al., 1985) , is thought to drive mechanical force feedback in the cochlea, thereby enhancing both the sensitivity and frequency selectivity of the mammalian ear (Dallos, 1992) . A potentially related property, OHC axial stiffness, is both voltage dependent (He and Dallos, 1999) and is reduced by acetylcholine (ACh)-elicited increase in intracellular calcium, one of the major features of suppressive feedback, cochlear gain regulation via the medial olivocochlear (MOC) efferents (Dallos et al., 1997) . Evidence suggests that prestin significantly contributes to the global OHC axial stiffness and that ACh affects both prestin and other lateral wall stiffness components (He et al., 2003) . A previous study reported alteration of OHC motor properties subsequent to addition of inhibitors of the ubiquitous and well characterized calciumresponsive protein calmodulin (CaM; Frolenkov et al., 2000) , which is highly expressed in OHCs (Slepecky and Ulfendahl, 1993) . In light of this knowledge, along with the rigor with which the function and physiology of prestin has been heretofore characterized, we chose prestin as a model SLC26 protein through which the nature of CaMbased regulatory mechanisms of SLC26 proteins might be explored.
Herein, we present evidence that CaM directly binds to the C-terminal domain of prestin in a calcium-obligate manner and that this binding significantly hyperpolarizes the voltageoperating point (V pk ) of prestin, which has the potential to modulate OHC axial stiffness attributable to variations in the state of individual prestin molecules (He and Dallos, 1999; He et al., 2003) . Moreover, we present clear bioinformatic evidence that this CaM-dependent regulatory mechanism can be extrapolated to all SLC26 proteins.
Materials and Methods
CaM binding assays. Recombinant human CaM was prepared as described previously (Ikebe et al., 1998) . A 30 aa peptide corresponding to gerbil prestin K557-N586 (KRKTGVNPALIMGARRKAMRKYAKEVGNAN) was synthesized with an N-terminal fluorescein label and was dissolved at 5 mM in water before storage at Ϫ80°C. Size exclusion chromatography (SEC) experiments were run using a Superdex 200 10/300 GL column on an AKTA purifier system in running buffer containing 150 mM NaCl and 10 mM Tris-HEPES, pH 7.5, supplemented with either 5 mM CaCl 2 or 5 mM Na-EDTA as dictated by the experiment. Injected samples were prepared by premixing 10 l of CaM stock at 20 mg/ml in 50 mM NaCl and 10 mM Tris-HEPES, pH 7.5, with 10 l of running buffer or peptide stock solution (water-dissolved peptide stock solution diluted in running buffer to 10 mg/ml), supplemented to 5 mM CaCl 2 or Na-EDTA and incubated at room temperature for ϳ20 min. Fractions (0.5 ml) were collected and subsequently analyzed on a fluorescence plate reader (BioTek) for measurement of fluorescence intensity and polarization signals. Fluorescence polarization experiments to determine the affinity of the CaM-peptide complex were performed as follows: 1:2 serial dilutions of CaM at 37.5 mg/ml in 50 mM NaCl and 25 mM Tris-Cl, pH 8.0, were made into measurement buffer containing 10 nM peptide, 20 mM Tris-HEPES, pH 8.0, 50 mM NaCl, 0.1% Tween 20, and 2 mM CaCl 2 . Polarization values were measured on a Panvera Beacon 2000 instrument in triplicate. Immediately after these measurements were made, Na-EDTA, pH 8.0, was added to the samples to 5 mM, and the fractions were remeasured. Resulting curves were plotted and fitted in GraphPad Prism using the Hill equation.
Electrophysiology. Adolescent FVB mice of both sexes (P37-P47) were killed with euthasol (200 mg/kg, i.p.), and OHCs from the apical region of the cochlea were isolated as described previously (Cheatham et al., 2005) . Wild-type (WT) and mutated gerbil recombinant prestin constructs were cloned into a pEGFP-N2 vector and expressed in HEK293T cells as described previously (Zheng et al., 2005; Homma et al., 2010) . Whole-cell nonlinear capacitance (NLC) recordings were performed using the Axopatch 200A amplifier (Molecular Devices). An intracellular solution contained the following (in mM): 150 CsCl, 2 MgCl 2 , 0.1 CaCl 2 (or 10 EGTA), and 10 (or 20) HEPES, pH 7.4. An extracellular solution contained the following (in mM): 150 NaCl, 2 MgCl 2 , 2 CoCl 2 , and 10 HEPES, pH 7.4. Osmolarity was adjusted to 340 mmol/kg with glucose. Intracellular pressure was kept at 0 mmHg. Data were collected by jClamp (SciSoft) using a fast Fourier transform-based admittance analysis to determine cell membrane capacitance (C m ) (Santos-Sacchi et al., 1998). C m data were analyzed using the following two-state Boltzmann equation:
where ␣ is the slope factor of the voltage dependence of charge transfer, Q max is the maximum charge transfer, V m is the membrane potential, V pk is the voltage at which the maximum charge movement per voltage is attained, and C lin is the linear capacitance (Homma et al., 2010 Homma and Dallos, 2011) .
Results
The SLC26 proteins contain ϳ750 aa divided into an intracellular N-terminal segment (ϳ100 residues), an intramembranous region (ϳ400 residues) that is predicted to contain 10 -12 transmembrane helices, and an intracellular C-terminal domain (ϳ250 residues) that contains a conserved sulfate transport and anti-sigma factor antagonist (STAS) domain (Sharma et al., 2011) . Based in part on a previous study of prestin (SLC26A5; Frolenkov et al., 2000) , we considered whether there might be a CaM-mediated regulatory mechanism common to all SLC26 proteins. As a first step, we explored the general sequence properties of SLC26 proteins using several bioinformatic approaches. The first of these was prediction of intrinsically disordered regions (IDRs), which revealed an area of high IDR likelihood in most of the STAS domains of the SLC26 proteins ( Fig. 1 A, C, plot labeled IDR). Difficulty in crystallizing the STAS domains of SLC26 proteins, including that of prestin (Babu et al., 2010; Pasqualetto et al., 2010) , can be at least partially explained by the presence of such high IDR likelihood regions, with IDR truncation apparently a sine qua non for success. Because CaM binding sites are often located in IDRs (Uversky and Dunker, 2010), these regions were of particular interest. To test these predictions empirically for the presence of IDRs, we ran SDS-PAGE gels of purified STAS constructs searching for one of the hallmarks of IDRs: aberrantly slow electrophoretic mobility (Radivojac et al., 2007) . This aberrant mobility (ϳ9 kDa upward shift between the calculated vs apparent molecular masses) was indeed found in all constructs tested (A3, A5, and A6) ( Fig. 1B) and was corroborated by similar mobility shifts in other orthologs Pasqualetto et al., 2008) . Subsequent limited trypsinolysis experiments on the prestin-STAS construct showed that the three sites most susceptible to trypsin digestion were located in the predicted IDR (K580, K606, and K622 in gerbil prestin), further corroborating its flexible nature and the amino acids potentially involved at the interface between prestin and CaM. Based on these considerations, the presence of IDRs in the C-terminal domains of the SLC26 proteins was highly likely. Because CaM binding sites (CBS) are frequently located in IDRs (Radivojac et al., 2006 (Radivojac et al., , 2007 , we used a well characterized CBS prediction program (Radivojac et al., 2006) to assess the likelihood of CBSs existing therein and found in each paralog a region of high CBS likelihood within the aforementioned IDR ( Fig. 1 A, C, plot labeled CaM). Because the scores were quite high across all of the homologs, this strongly suggested physiological binding of CaM. Furthermore, because the sites were located in IDRs, the CBS would be accessible for binding to CaM. We consider in more depth the statistics of the predictor and their ramifications in the discussion section below. These data together indicated that all SLC26 homologs tested have IDRs and bind CaM.
To demonstrate empirically CaM binding and its functional consequences, we chose to focus on prestin (SLC26A5) as a model for the SLC26 family because it is the best characterized member in terms of structure (Pasqualetto et al., 2010 ) and func- tion (Ashmore, 2008) . Using a 30 aa fluorescein-tagged peptide corresponding to the predicted CBS in prestin ( Fig. 1 A, C , horizontal bars in prestin IDR and CaM plots), we performed SEC on combinations of calcium, CaM, and peptide to determine whether-and under which conditions-a CaM-peptide complex would form (Fig. 2 A, B) . Coelution of fluorescein-peptide signal (Fig. 2 A, B , green lines) with CaM occurred in the presence of calcium (Fig. 2B , solid red trace) but not appreciably in its absence ( Fig. 2A, solid blue trace) , revealing an unambiguous calcium-obligate interaction. However, in the course of analyzing these data, we noticed a surprising phenomenon brought about by the presence of peptide: whereas in the EDTA condition the small peptide-containing shoulder ( Fig. 2A , solid blue line) was unremarkably of apparently higher molecular weight than apoCaM ( Fig. 2A , broken blue line) in the calcium condition, the single peak corresponding to the peptide-CaM complex (Fig. 2B , solid red line) was robustly and repeatedly shifted in the direction of lower apparent molecular weight compared with CaM alone (Fig. 2B, broken red line) . Although unexpected at first, the result is readily understood considering the phenomenon, documented in the literature, of other CaM-peptide complexes having smaller hydrodynamic radii than unbound CaM, despite their moderately (ϳ3 kDa) higher molecular weight. Although molecular weight and hydrodynamic radius generally covary, CaM and its peptide complexes violate this rule because of the extended conformation of unbound CaM versus the more compact conformations of CaM-peptide complexes. Because SEC effectively measures not molecular weight but hydrodynamic radius, the initially surprising result provided support for the prestin-CaM interaction being similar to the canonical complexes rather than the more recently elucidated unconventional examples. Ironically, in light of this explanation, the complex observed in the EDTA condition now required explanation: this complex must have a larger hydrodynamic radius than when CaM is unbound, consistent with an open, extended peptide-bound conformation. However, because only a small fraction of CaM eluted as a complex despite the presence of excess peptide in the sample, we evaluated the calcium-independent CaM-peptide interaction to be of low affinity (quantified below) and therefore possibly an experimental artifact of dubious physiological relevance. To explore this further, the affinities of the interaction were subsequently determined by a fluorescence polarization assay (Fig. 2C ) to be 86.5 nM (CaCl 2 ) and 73.4 M (EDTA), i.e., an ϳ1000-fold difference. Similarly sized fluorescein-tagged control peptides showed essentially no binding (K d Ͼ 100 M) regardless of calcium. Both affinity and calcium responsiveness were consistent with values reported for verified physiological CaM-peptide interactions, with a mean K d value at ϳ130 nM (O'Neil and DeGrado, 1990 ). Hence, the bioinformatics predictions were corroborated empirically, and the interaction was shown to be of high affinity and to require calcium.
We also considered the ramifications of the CaM-prestin interaction in cochlear physiology and endeavored to measure the effects of the interaction in conditions more closely resembling those in vivo. ACh is used by the MOC efferents to modulate cochlear amplification (Eybalin, 1993) . It was reported previously that ACh induces a small but statistically significant hyperpolarizing shift (Ϫ4 mV) in the V pk of prestin (Frolenkov et al., 2000) , as well as a reduction in the axial stiffness of the OHC (Dallos et al., 1997) through elevations in intracellular calcium. We speculated that the direct prestin-CaM interaction demonstrated above might be at least partially responsible for these changes. Because the aforementioned calcium effect on V pk was seen even under weak calcium-chelating conditions (0.5 mM EGTA; Frolenkov et al., 2000) , removal of EGTA might unmask an even larger effect. To this end, we measured whole-cell NLC in mouse OHCs as a function of intracellular calcium (Fig. 3A-C,E) . As predicted, large hyperpolarizing V pk shifts (Ϫ35 Ϯ 19 mV) were observed with intracellularly applied calcium. These hyperpolarizing V pk shifts were reversed during local perfusion of the CaM inhibitor trifluoperazine (TFP), indicating that the V pk shift was, in fact, both dependent on CaM and readily reversible (Fig.  3 D, E) . As control recordings to assess a potential effect of extracellular calcium on our whole-cell NLC recordings, we compared NLCs measured in the presence and absence of extracellular calcium. The ␣, V pk , and charge density values determined in the presence (2 mM CaCl 2 ) and absence (2 mM CoCl 2 ) of extracellular calcium were statistically insignificant [0.032 Ϯ 0.003 mV (n ϭ 5, Ca 2ϩ ) vs 0.028 Ϯ 0.004 mV Ϫ1 (n ϭ 8, Co 2ϩ ; p ϭ 0.11), Ϫ82 Ϯ 9 mV (n ϭ 5, Ca 2ϩ ) vs Ϫ79 Ϯ 11 mV (n ϭ 8, Co 2ϩ ; p ϭ 0.55), and 145 Ϯ 16 fC/pF (n ϭ 5, Ca 2ϩ ) vs 150 Ϯ 19 fC/pF (n ϭ 8, Co 2ϩ ; p ϭ 0.66)], confirming that our NLC recordings were not affected by the nominal calcium-free extracellular solution used in this study (for the ionic composition; see Materials and Methods).
To address the possibility of CaM acting indirectly or upstream of prestin, as well as to confirm involvement of the IDR within prestin, we measured the calcium-induced shift in two different CBS-altered prestin constructs (Fig. 4) transfected into HEK293T cells (Fig. 5) , both of which completely abrogate bioinformatic CBS predictions (Fig. 4) . After confirming the presence of the calcium-induced V pk shift in HEK293T cells transfected with WT prestin (Fig. 5 A, B) , as well as its TFP sensitivity (Fig.  5C,D) , we measured the effect in a CBS-deleted construct (⌬571-635, referred to as ⌬CBS) and found that this mutation completely abolished the calcium-dependent shift in V pk (Fig. 5 E, F ) , mimicking the effects of TFP on WT prestin. We cross-validated this result with an additional CaM binding-deficient mutant in which six of the basic residues (R571, R572, K573, R576, K577, and K580) in the CBS were all mutated to aspartates to abrogate CaM binding ("flipCBS"; Bai et al., 2006) and found that the V pk of this mutant also does not respond to intracellularly applied calcium (Fig. 5G,H ) . These electrophysiological experiments, together with the bioinformatic and biochemical experiments detailed above, demonstrate that direct binding of CaM to the IDR in the intracellular C-terminal STAS domain of prestin causes hyperpolarizing shifts in the voltage dependence (V pk ) of prestin and presumably affects other SLC26 proteins in similar ways, although perhaps with different consequences, i.e., differences in transport activity rather than electromotility.
Discussion
It is important first to consider the quantitative aspects and ramifications of the bioinformatic predictions of CBSs both with re- gard to prestin as well as the rest of the SLC26 protein family (Fig. 1) . Although some bioinformatics programs are poorly characterized in terms of the meaning of a given score, this particular predictor (Radivojac et al., 2006) has been quantified rigorously by using training and test sets of the hundreds of known CBSs, allowing the output scores to be cast reliably as either sensitivities and specificities or, perhaps more usefully, Bayesian likelihood ratios (LRs) (Fig. 6A) . For example, with this predictor, scores 0.92-seen in many of the SLC26 paralogs (Fig. 1A,C) correspond to LRs Ͼ30. To put this number in context, the average LR of ϳ50 common clinical tests was 16.8, with a median of 6.8 (reported at http://www.med. unc.edu/medicine/edursrc/lrtest.htm). Using the Bayesian formalism, one can use this LR value mathematically to convert prior probabilities into posterior probabilities (Fig. 6B ). An approach to generalization of the current bioinformatic results then might be to determine what prior probability would lead to a posterior probability of Ͼ0.95 (analogous to p Ͻ 0.05), given the observed predictor scores, and then evaluate how this number corresponds to estimates of actual prior probabilities. In the case of most of the SLC26 family, this requisite prior probability is 0.38. As a minimal baseline, assuming there are at least 200 CaM targets in the proteome (some reports suggest many more than that; Shen et al., 2005) and a proteome size of 20,000 proteins, the prior probability for any protein would be 0.01, with the corresponding posterior probability of 0.23 given scores equivalent to those observed for the SLC26 proteins. Starting first with prestin, for which the current study provides strong empirical evidence, the prior probability would easily surpass 0.38, leading to a posterior probability of Ͼ Ͼ0.95, and this would propagate to other prestin orthologs because of their very high sequence similarity.
Although extrapolation to the SLC26 paralogs of prestin might be less straightforward, there are nevertheless some considerations that may make the case stronger. First, the entire family shares similar sequence, predicted secondary structure, and predicted topology, suggesting a similarity in architecture that may parallel a similarity in functional mechanism. Second, there are many functional studies that show similarity in chloride involvement, CFTR binding, and epithelial targeting. Third, and perhaps most saliently, several of the non-prestin paralogs have been shown previously to be functionally modulated by intracellular calcium [SLC26A3 (Lamprecht et al., 2009) , SLC26A5 (the present study and Frolenkov et al., 2000; He et al., 2003) , and SLC26A9 (Loriol et al., 2008) ]. We suggest that there is a very high likelihood that at least the high-scoring paralogs in the SLC26 family share the prestin attribute of calcium/ CaM-based functional modulation.
The functional data presented above indicate that the voltage-dependent energy states of prestin, as represented by V pk , are perturbed by the binding of CaM.
In light of what is known about cochlear and OHC physiology, the ramifications and mechanism of the interaction are straightforward. Because it has been shown that voltage-dependent OHC stiffness is intimately related to the V pk of prestin, it follows that cochlear mechanics and, hence, cochlear amplification, would be affected by CaM-prestin binding. Furthermore, because MOC activity both elevates OHC calcium as well as suppresses cochlear amplification, it appears likely that the CaM-prestin interaction plays a role in modulation of cochlear amplification via MOC effects.
However, what may remain unclear is how CaM-induced changes in the V pk of prestin correspond to aspects of molecular function in other SLC26 homologs. Although there is a possibility that CaM exerts its effects on SLC26 proteins in homolog-specific ways, we propose the formulation of a general mechanism of CaM-induced inhibition involving perturbations of relative energies of transporter states or analogous conformational states, as follows. Although the degree to which the voltage-dependent states of prestin correspond to vestigial transporter states remains controversial, all agree that there is some relationship, albeit to varying degrees under different conditions. Because there is some degree of correspondence then, the NLC of prestin may be considered a reflection of the relative energy of the vestigial transporter states of prestin, with V pk representing the transmembrane voltage at which the energies of the transporter states are equal. It then follows that CaM binding, insofar as it affects V pk , affects the relative energies of the vestigial transporter states of prestin. In light of this reasoning, generalizing to other SLC26 homologs becomes more understandable, because other homologs presumably have not merely vestigial but actual bona fide transporter states, e.g., outward and inward facing. When CaM binds these transporters, the relative energies of the conformational states would be perturbed, which would potentially result in alterations of transporter kinetics, electrogenicity, and/or rectification. et al., 2008)], consistent with the generality of the CaM interaction proposed here, it will be intriguing to see which of these functional consequences, if any, occur as a result of CaM binding to the other SLC26 transporters.
